Evidence map›Paper›PMID 30353262›Full record

Trial reportEuropean archives of psychiatry and clinical neuroscience2020

Default mode network connectivity change corresponds to ketamine's delayed glutamatergic effects.

Meng Li, Marie Woelfer, Lejla Colic, Adam Safron, Catie Chang, Hans-Jochen Heinze, Oliver Speck, Helen S Mayberg, Bharat B Biswal, Giacomo Salvadore and 2 more

Abstract readRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in European archives of psychiatry and clinical neuroscience, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 3 pooled it
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 3 syntheses or guidelines pooled it, 56 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. MDMA-induced changes in within-network connectivity contradict the specificity of these alterations for the effects of serotonergic hallucinogens.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2021
    Trial
  6. Trial
  7. Detecting neuroplastic effects induced by ketamine in healthy human subjects: A multimodal approach.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2026
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 9 institutions in 2 countries.

Meng LiClinical Affective Neuroimaging Laboratory, Leibniz Institute for Neurobiology, Magdeburg, Germany.
Marie WoelferClinical Affective Neuroimaging Laboratory, Leibniz Institute for Neurobiology, Magdeburg, Germany.
Lejla ColicClinical Affective Neuroimaging Laboratory, Leibniz Institute for Neurobiology, Magdeburg, Germany.
Adam SafronDepartment of Psychology, Northwestern University, Evanston, IL, USA.
Catie ChangDepartment of Electrical Engineering and Computer Science, Vanderbilt University, Nashville, TN, USA.
Hans-Jochen HeinzeDepartment of Neurology, Otto-von-Guericke-University, Magdeburg, Germany.
Oliver SpeckDepartment Behavioral Neurology, Leibniz Institute for Neurobiology, Magdeburg, Germany.
Helen S MaybergDepartment of Neurology and Neurosurgery, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Bharat B BiswalNew Jersey Institute of Technology, Newark, NJ, USA.
Giacomo SalvadoreJanssen Research and Development, Titusville, NJ, USA.
Anna FejtovaCenter for Behavioral Brain Sciences (CBBS), Magdeburg, Germany.
Martin WalterClinical Affective Neuroimaging Laboratory, Leibniz Institute for Neurobiology, Magdeburg, Germany. martin.walter@uni-tuebingen.de.
Leibniz Institute for Neurobiology · DEFriedrich-Alexander-Universität Erlangen-Nürnberg · DEGerman Center for Neurodegenerative Diseases · DEIcahn School of Medicine at Mount Sinai · USJanssen (United States) · USNew Jersey Institute of Technology · USNorthwestern University · USOtto-von-Guericke University Magdeburg · DEVanderbilt University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ketamine exerts rapid antidepressant effects peaking 24 h after a single infusion, which have been suggested to be reflected by both reduced functional connectivity (FC) within default mode network (DMN) and altered glutamatergic levels in the perigenual anterior cingulate cortex (pgACC) at 24 h. Understanding the interrelation and time point specificity of ketamine-induced changes of brain circuitry and metabolism is thus key to future therapeutic developments. We investigated the correlation of late glutamatergic changes with FC changes seeded from the posterior cingulate cortex (PCC) and tested the prediction of the latter by acute fractional amplitude of low-frequency fluctuations (fALFF). In a double-blind, randomized, placebo-controlled study of 61 healthy subjects, we compared effects of subanesthetic ketamine infusion (0.5 mg/kg over 40 min) on resting-state fMRI and MR-Spectroscopy at 7 T 1 h and 24 h post-infusion. FC decrease between PCC and dorsomedial prefrontal cortex (dmPFC) was found at 24 h post-infusion (but not 1 h) and this FC decrease correlated with glutamatergic changes at 24 h in pgACC. Acute increase in fALFF was found in ventral PCC at 1 h which was not observed at 24 h and inversely correlated with the reduced dPCC FC towards the dmPFC at 24 h. The correlation of metabolic and functional markers of delayed ketamine effects and their temporal specificity suggest a potential mechanistic relationship between glutamatergic modulation and reconfiguration of brain regions belonging to the DMN.

Indexed as

ConnectomeAdultDouble-Blind MethodExcitatory Amino Acid AntagonistsFemaleGlutamic AcidGyrus CinguliHumansKetamineMagnetic Resonance ImagingMagnetic Resonance SpectroscopyMaleNerve NetPrefrontal CortexYoung AdultExcitatory Amino Acid AntagonistsGlutamic AcidKetamineDorsal posterior cingulate cortexFunctional connectivityGlutamateKetamineMagnetic resonance spectroscopyResting state fMRI

Identifiers

PMID30353262
OpenAlexW2896803831

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.